Gonadorelin 10 mg
Main Image

Gonadorelin 10 mg

Steroids Dragon Pharma Peptide

$26.40

Gonadorelin 10 mg – Peptide Hubs

Gonadorelin is a synthetic analog of natural gonadotropin-releasing hormone (GnRH), used in research to stimulate the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. The 10 mg lyophilized format by Peptide Hubs is designed for precise hormonal research involving fertility, testosterone regulation, and hypothalamic-pituitary-gonadal (HPG) axis function.

Mechanism of Action

Gonadorelin binds to GnRH receptors in the pituitary gland, leading to an acute surge in LH and FSH. This in turn stimulates the gonads to produce testosterone or estrogen depending on the sex of the model organism. It is often used to evaluate fertility function, testicular recovery, and feedback mechanisms. Gonadorelin is also explored in studies related to hypogonadism and HCG/LH synergy. See this NCBI resource on Gonadorelin pharmacology.

Primary Research Applications

  • Stimulation of LH and FSH release in HPG axis models
  • Investigation of fertility and testosterone recovery
  • Evaluation of hypothalamic or pituitary function
  • Comparative studies with HCG or Clomiphene Citrate

Gonadorelin may be stacked with HCG 2500 IU or Clomiphene Citrate for post-cycle therapy (PCT) studies or testosterone reactivation protocols. It can also be used in cycles evaluating the impact of androgens on fertility markers when used alongside compounds like GHRP-6 or DSIP.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma
Manufacturer: Dragon Pharma
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <ul> <li><strong>Dosage:</strong> 100–500 mcg per dose in single or pulsatile protocols</li> <li><strong>Administration:</strong> Subcutaneous or intravenous injection</li> <li><strong>Cycle Duration:</strong> Short-term stimulation (1–14 days typical in models)</li> </ul> <h3>Stacking Options</h3> <ul> <li>GHRP-2 – for synergy in GH + LH/FSH pulse studies</li> <li>Chonluten – to study hormone–immune axis balance</li> <li>AOD 9604 – to explore gonadal recovery and fat regulation</li> <li>GHK Basic – for testicular support and recovery analysis</li> </ul> <h3>Safety &amp; Legal Status</h3> <p>Gonadorelin 10 mg is intended strictly for **research purposes only**. It is not approved for medical use and must not be used in humans outside controlled lab environments. No aromatization, liver toxicity, or androgenic activity is reported. Short half-life may require frequent dosing in research protocols. For ongoing studies, visit <a href="https://clinicaltrials.gov/" rel="noopener" target="_blank">ClinicalTrials.gov</a>.</p> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Synthetic GnRH Decapeptide
Peptide Sequence
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂
Peptide Length
10 Amino-Acid Residues
Terminal Structure
N-Terminal Pyroglutamate · C-Terminal Amide
Molecular Formula
C₅₅H₇₅N₁₇O₁₃
Molecular Weight
1182.3 g/mol
CAS Number
33515-09-2
PubChem CID
638793
Receptor Target
GnRH Receptor (GnRHR)
Endocrine Pathway
Hypothalamic–Pituitary–Gonadal Axis

Chat on WhatsApp